ATE521622T1 - ßNEUE PEPTIDE, DEREN DERIVATE, VERFAHREN ZU DEREN HERSTELLUNG, NEUE STÄMME, DIE DIESE SUBSTANZEN PRODUZIEREN, UND ANTIVIRALE MITTEL, DIE DIESE SUBSTANZEN ALS WIRKSTOFFE ENTHALTENß - Google Patents

ßNEUE PEPTIDE, DEREN DERIVATE, VERFAHREN ZU DEREN HERSTELLUNG, NEUE STÄMME, DIE DIESE SUBSTANZEN PRODUZIEREN, UND ANTIVIRALE MITTEL, DIE DIESE SUBSTANZEN ALS WIRKSTOFFE ENTHALTENß

Info

Publication number
ATE521622T1
ATE521622T1 AT02711381T AT02711381T ATE521622T1 AT E521622 T1 ATE521622 T1 AT E521622T1 AT 02711381 T AT02711381 T AT 02711381T AT 02711381 T AT02711381 T AT 02711381T AT E521622 T1 ATE521622 T1 AT E521622T1
Authority
AT
Austria
Prior art keywords
substances
peptides
derivatives
ßnew
antiviral agents
Prior art date
Application number
AT02711381T
Other languages
English (en)
Inventor
Masahiro Ishima
Tsutomu Yoshida
Takayuki Yamazaki
Fumio Sugawara
Kiyoshige Hatta
Manabu Shimojoe
Kazuyoshi Masaki
Original Assignee
Toyo Suisan Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Suisan Kaisha filed Critical Toyo Suisan Kaisha
Application granted granted Critical
Publication of ATE521622T1 publication Critical patent/ATE521622T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT02711381T 2001-02-08 2002-02-07 ßNEUE PEPTIDE, DEREN DERIVATE, VERFAHREN ZU DEREN HERSTELLUNG, NEUE STÄMME, DIE DIESE SUBSTANZEN PRODUZIEREN, UND ANTIVIRALE MITTEL, DIE DIESE SUBSTANZEN ALS WIRKSTOFFE ENTHALTENß ATE521622T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001032729 2001-02-08
PCT/JP2002/001039 WO2002062831A1 (en) 2001-02-08 2002-02-07 Novel peptides, derivatives thereof, process for producing the same, novel strains producing the same and antiviral agents containing the same as the active ingedient

Publications (1)

Publication Number Publication Date
ATE521622T1 true ATE521622T1 (de) 2011-09-15

Family

ID=18896612

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02711381T ATE521622T1 (de) 2001-02-08 2002-02-07 ßNEUE PEPTIDE, DEREN DERIVATE, VERFAHREN ZU DEREN HERSTELLUNG, NEUE STÄMME, DIE DIESE SUBSTANZEN PRODUZIEREN, UND ANTIVIRALE MITTEL, DIE DIESE SUBSTANZEN ALS WIRKSTOFFE ENTHALTENß

Country Status (5)

Country Link
US (1) US7268209B2 (de)
EP (2) EP1369426B1 (de)
JP (1) JP3990284B2 (de)
AT (1) ATE521622T1 (de)
WO (1) WO2002062831A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102026645B (zh) 2006-09-15 2016-01-27 渥太华医院研究机构 溶瘤弹状病毒
CN105541963A (zh) * 2015-08-31 2016-05-04 深圳出入境检验检疫局食品检验检疫技术中心 一种在蛋白质上修饰烯酰基团的方法
WO2020196315A1 (ja) * 2019-03-25 2020-10-01 国立大学法人筑波大学 細胞層透過促進剤、薬剤吸収補助用組成物、及び医薬組成物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0195792A (ja) * 1987-10-07 1989-04-13 Sapporo Breweries Ltd 新規４６ｎｗ−０４ａ物質，その製造法およびそれを有効成分とする抗ウィルス製剤
US5965524A (en) * 1989-07-07 1999-10-12 Peptide Technologies Corporation Analogs of viscosin and uses thereof
US5258493A (en) * 1989-07-07 1993-11-02 Bio-Mega/Boehringer Ingelheim Research Inc. Cyclic peptides for treating herpes infections
DK223690D0 (da) * 1990-09-17 1990-09-17 Novo Nordisk As Hidtil ukendte forbindelser
US6319898B1 (en) * 1997-10-17 2001-11-20 Terragen Diversity, Inc. Method for inhibiting eukaryotic protein kinases
HUP0200897A2 (en) * 1999-04-15 2002-08-28 Lilly Co Eli Antifungal agents isolated from pseudomonas syringae

Also Published As

Publication number Publication date
EP1369426A4 (de) 2005-11-30
WO2002062831A1 (en) 2002-08-15
US20040102605A1 (en) 2004-05-27
JPWO2002062831A1 (ja) 2004-06-10
EP1369426A1 (de) 2003-12-10
EP2116552A3 (de) 2010-04-28
US7268209B2 (en) 2007-09-11
JP3990284B2 (ja) 2007-10-10
EP1369426B1 (de) 2011-08-24
EP2116552A2 (de) 2009-11-11

Similar Documents

Publication Publication Date Title
BR0214679A (pt) Composições farmacêuticas compreendendo compostos a base de vitamina d ativa
NO20034149D0 (no) Legemidler inneholdende triazaspiro[5.5]undekanderivater som den aktive bestanddel
EP1100522A4 (de) Verabreichung aktiver wirkstoffe über die lunge
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
TR200200785T2 (tr) 8-Fenil-6,9-dihidro-[1,2,4] triazolo [3,4-i] purin-5-on türevleri
DE60314633D1 (de) Substituierte 1,3-diphenylprop-2-en-1-on derivate, deren herstellung und anwendungen
TR200302214T4 (tr) Psoriasis tedavisi için kullanilan pteridine bileşkenleri
BRPI0411306A (pt) composições farmacêuticas compreendendo compostos ativos de vitamina d
ATE473976T1 (de) Dipeptidylpeptidase-iv-inhibierende verbindungen, verfahren zu deren herstellung und pharmazeutische zusammensetzungen, die diese als wirkstoffe enthalten
DZ3197A1 (fr) Acides aminés bicycliques utilises comme agents pharmaceutiques.
FI964285A0 (fi) Taksaanien luokkaan kuuluviin johdannaisiin perustuvat farmaseuttiset valmisteet
WO2003104425A3 (en) NEW STABLE ANTI-CD22 ANTIBODIES
TR199700711T1 (xx) Ciltten ge�erek v�cuda giren form�lasyon.
DE60210598D1 (de) 3,7-DIAZABICYCLOc3.3.1Ü-FORMULIERUNGEN ALS ANTIARRHYTHMIKA
SE9804212D0 (sv) Compounds
DE69706146D1 (de) Taxoide, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen
ITMI20022394A1 (it) Uso di triiodotironina 3-solfato come farmaco ad attivita' tireomimetica e relative formulazioni farmaceutiche.
BR0207066A (pt) Derivados do 2h-1-benzopirano - processos para sua preparação e composições farmacêuticas a partir deles
ES2124861T3 (es) Derivados de aminoacidos y su utilizacion como inhibidores de la encefalinasa.
ATE286893T1 (de) 2h-1-benzopyran-derivative, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
SE0001916D0 (sv) Novel formulation
ATE338567T1 (de) Pharmazeutische zubereitungen, wirkstoffe enthaltend, die sich für unerlaubte verabreichung anbieten
ATE289595T1 (de) Neue pyrimidin-2,4,6-trion-derivate, verfahren zu ihrer herstellung und pharmazeutische mittel die diese enthalten
EP0937708A3 (de) Sulfonamid-Derivate
DE69931038D1 (de) Neue polysaccharidderivate, verfahren zu ihrer herstellung und medizinische zusammensetzungen die diese als aktives bestandteil enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties